Overexpression of podoplanin in oral cancer and its association with poor clinical outcome.

Abstract:

BACKGROUND:Podoplanin is a mucin-like glycoprotein that is important in lymphangiogenesis but not blood vessel formation. Recent studies suggested a potential role of podoplanin in certain tumor cells. The purpose of the current study was to determine the role of podoplanin in head and neck squamous cell carcinoma (HNSCC). METHODS:Podoplanin expression was analyzed in 35 patients with HNSCC including 16 oral tumors and 19 hypopharyngeal tumors by immunohistochemical analysis and the association between the podoplanin expression status and patients' clinical and pathologic characteristics was evaluated. An independent set of 60 patients with oral tongue cancer was then analyzed for associations between the podoplanin expression status and patients' clinical and pathologic characteristics, including survivals. RESULTS:Podoplanin was not expressed in normal oral epithelial cells but was detected in some hyperplastic and dysplastic lesions. High podoplanin expression was found in 20 (57%) of the 35 tumors and was more frequent in tumors with lymph node metastasis, particularly for tumors in the oral cavity. In the second set of 60 oral tongue cancers, 36 (60%) expressed high levels of podoplanin. Patients whose tumors expressed high levels of podoplanin had a statistically significantly higher rate of lymph node metastasis (P < .0001). Patients with lymph node metastasis and high-level podoplanin showed the shortest disease-specific survival (P = .0004) than other patients. CONCLUSIONS:Podoplanin is involved in oral tumorigenesis and may serve as a predictor for lymph node metastasis and poor clinical outcome.

journal_name

Cancer

journal_title

Cancer

authors

Yuan P,Temam S,El-Naggar A,Zhou X,Liu DD,Lee JJ,Mao L

doi

10.1002/cncr.22061

subject

Has Abstract

pub_date

2006-08-01 00:00:00

pages

563-9

issue

3

eissn

0008-543X

issn

1097-0142

journal_volume

107

pub_type

杂志文章

相关文献

CANCER文献大全
  • Phase II evaluation of topotecan for pediatric central nervous system tumors.

    abstract:BACKGROUND:Topotecan is a topoisomerase I inhibitor that has good penetration across the blood-brain barrier and significant antitumor activity against human brain tumor xenografts. In a Phase I trial in children with refractory cancer, topotecan was well tolerated when administered as a 24-hour infusion. The maximum t...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/(SICI)1097-0142(19960801)78:3<527::AID-CNC

    authors: Blaney SM,Phillips PC,Packer RJ,Heideman RL,Berg SL,Adamson PC,Allen JC,Sallan SE,Jakacki RI,Lange BJ,Reaman GH,Horowitz ME,Poplack DG,Balis FM

    更新日期:1996-08-01 00:00:00

  • Myeloproliferative disorder with unusual marrow chromosome constitution.

    abstract::This report describes a patient referred at 14 years in 1971, after one year's surveillance by the family physician, for a persistently elevated erythrocyte sedimentation rate, leukopenia, and relative lymphocytosis. Despite the documented myeloproliferative syndrome of seven years, significant physiologic impairment ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810901)48:5<1164::aid-cncr2820

    authors: Whaun JM,Lin CC,Biederman B,Cornish SJ,Dundas JB

    更新日期:1981-09-01 00:00:00

  • Immunohistochemical and cytogenetic studies indicate that malignant angioendotheliomatosis is a primary intravascular (angiotropic) lymphoma.

    abstract::The authors performed immunohistochemical and cytogenetic studies in a 73-year old man with malignant angioendotheliomatosis. The patient was referred for evaluation of fever of unknown origin, hepatic failure, and neurologic deterioration. Examination of a muscle biopsy revealed numerous, noncohesive atypical mononuc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900801)66:3<474::aid-cncr28206

    authors: Molina A,Lombard C,Donlon T,Bangs CD,Dorfman RF

    更新日期:1990-08-01 00:00:00

  • The value of fine-needle aspiration biopsy in the differential diagnosis of adult myxoid sarcoma.

    abstract:BACKGROUND:The usefulness of fine-needle aspiration biopsy (FNAB) for the histologic subtyping of specific sarcomas still is somewhat controversial but is becoming increasingly popular in the U.S. METHODS:To determine the accuracy and usefulness of FNAB in the differential diagnosis of myxoid sarcoma, the authors retr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20000625)90:3<167::aid-cncr5>3.0

    authors: Kilpatrick SE,Ward WG,Bos GD

    更新日期:2000-06-25 00:00:00

  • Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity.

    abstract:BACKGROUND:Total body irradiation (TBI) is commonly used with autologous bone marrow transplantation (BMT) for treatment of hematologic malignancies. Pulmonary complications of TBI can cause long-term morbidity and mortality. The authors have compared the pulmonary toxicity and efficacy of two different TBI fractionati...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(20011001)92:7<1949::aid-cncr1714

    authors: Gopal R,Ha CS,Tucker SL,Khouri IF,Giralt SA,Gajewski JL,Andersson BS,Cox JD,Champlin RE

    更新日期:2001-10-01 00:00:00

  • Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis.

    abstract:BACKGROUND:Thyroid tumorigenesis is characterized by a progressive loss of differentiation exhibited by a range of disease variants. The Notch receptor family (1-4) regulates developmental progression in both normal and cancerous tissues. This study sought to characterize the third Notch isoform (Notch3) across the var...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30403

    authors: Somnay YR,Yu XM,Lloyd RV,Leverson G,Aburjania Z,Jang S,Jaskula-Sztul R,Chen H

    更新日期:2017-03-01 00:00:00

  • Antigenic markers of hepatocellular carcinoma.

    abstract::One hundred thirty-five hepatocellular carcinomas were examined for the presence of antigenic tumor markers by the avidin-biotin-peroxidase complex method. Ninety-seven were from the US and 38 came from Argentina. The following markers were tested: alpha-fetoprotein (AFP), alpha-1-antitrypsin (AAT), hepatitis B surfac...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900101)65:1<84::aid-cncr282065

    authors: Chedid A,Chejfec G,Eichorst M,Villamil F,Terg R,Telenta M,Hojman R

    更新日期:1990-01-01 00:00:00

  • Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes.

    abstract:BACKGROUND:The development of novel therapies for the myelodysplastic syndromes (MDS) is hampered by inadequate trial recruitment. Factors contributing to low trial accrual are incompletely understood. METHODS:This study analyzed a pooled patient database from institutions of the US MDS Clinical Research Consortium to...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33105

    authors: Brierley CK,Zabor EC,Komrokji RS,DeZern AE,Roboz GJ,Brunner AM,Stone RM,Sekeres MA,Steensma DP

    更新日期:2020-11-01 00:00:00

  • Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer.

    abstract::Androgen deprivation therapy (ADT) is now a well-established standard of care in combination with definitive radiotherapy for patients with unfavorable intermediate-risk to high-risk locally advanced prostate cancer. It is also well established that combination modality treatment with ADT and radiotherapy is superior ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.28594

    authors: Roach M 3rd

    更新日期:2014-06-01 00:00:00

  • Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel.

    abstract:BACKGROUND:In the AFFIRM trial, enzalutamide significantly increased overall survival (OS) for men with metastatic castration-resistant prostate cancer (mCRPC) after chemotherapy versus placebo and significantly decreased prostate-specific antigen (PSA) levels. The goal of this post hoc analysis was to associate levels...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.30587

    authors: Armstrong AJ,Saad F,Phung,Dmuchowski C,Shore ND,Fizazi K,Hirmand M,Forer D,Scher HI,Bono J

    更新日期:2017-06-15 00:00:00

  • Synovial sarcoma. A DNA flow cytometric study.

    abstract::The relationship between DNA content, clinicopathologic findings, and patient survival in synovial sarcoma was investigated. Patient age at diagnosis (P less than 0.001), tumor size (P less than 0.001), and ploidy status (P less than 0.003) correlated significantly with patient survival. A marginally significant corre...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900515)65:10<2295::aid-cncr282

    authors: el-Naggar AK,Ayala AG,Abdul-Karim FW,McLemore D,Ballance WW,Garnsey L,Ro JY,Batsakis JG

    更新日期:1990-05-15 00:00:00

  • Basic fibroblast growth factor and somatomedin C in human medulloepithelioma.

    abstract::Two published cases of medulloepithelioma, a rare malignant pediatric brain tumor composed of a mixture of primitive neuroepithelium and its differentiated neuronal and glial descendants, were examined by immunohistochemical staining for the presence of growth factors. From a panel of antibodies, those identifying bas...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19910815)68:4<798::aid-cncr28206

    authors: Shiurba RA,Buffinger NS,Spencer EM,Urich H

    更新日期:1991-08-15 00:00:00

  • Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.

    abstract:BACKGROUND:The objectives of this study were to evaluate survival among current smokers, former smokers, and never smokers who are diagnosed with non-small cell lung cancer (NSCLC). METHODS:The study included patients who participated in the National Comprehensive Cancer Network's NSCLC Database Project. Current, form...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27824

    authors: Ferketich AK,Niland JC,Mamet R,Zornosa C,D'Amico TA,Ettinger DS,Kalemkerian GP,Pisters KM,Reid ME,Otterson GA

    更新日期:2013-02-15 00:00:00

  • Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial.

    abstract:BACKGROUND:Follow-through of a positive screening test is necessary to reap the potential benefits of cancer screening. Racial variation in follow-through diagnostic care may underlie a proportion of the known disparity in prostate cancer mortality. The authors used data from the screening arm of the Prostate, Lung, Co...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.28042

    authors: Barocas DA,Grubb R 3rd,Black A,Penson DF,Fowke JH,Andriole G,Crawford ED

    更新日期:2013-06-15 00:00:00

  • Prognostic variables in mycosis fungoides.

    abstract::The prognostic importance of various factors was analyzed for 347 patients registered by the Mycosis Fungoides Cooperative Group (MFCG). Extent of skin involvement at the time of registration and number of sites of clinically enlarged lymph nodes were clearly the most important prognostic variables, and were combined ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810601)47:11<2671::aid-cncr282

    authors: Green SB,Byar DP,Lamberg SI

    更新日期:1981-06-01 00:00:00

  • Determinants of the recommended phase 2 dose of molecular targeted agents.

    abstract:BACKGROUND:The recommended phase 2 dose (RP2D) of anticancer agents is determined traditionally by dose-limiting toxicities. Nontoxicity or biological endpoints such as pharmacokinetics, pharmacodynamics, and efficacy can also be used to identify RP2D, which may be relevant to molecularly targeted agents (MTAs). METHO...

    journal_title:Cancer

    pub_type: 杂志文章,meta分析

    doi:10.1002/cncr.30579

    authors: Hansen AR,Cook N,Amir E,Siu LL,Abdul Razak AR

    更新日期:2017-04-15 00:00:00

  • Deferred therapy in patients with advanced disease.

    abstract::Disease that is known to have extended beyond the prostatic capsule is unlikely to be cured by radical surgical excision, although the primary tumor may be controlled by external irradiation. The development of progressive (metastatic) disease is common and may be retarded by hormonal therapy. The timing of such treat...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19930201)71:3+<1074::aid-cncr282

    authors: Smith PH

    更新日期:1993-02-01 00:00:00

  • Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.

    abstract:BACKGROUND:The causal relation between high-risk human papillomavirus (HPV) and cervical cancer and its precursor lesions has led to the use of sensitive HPV molecular tests for screening. This study examined the impact of the baseline HPV status on the future risk of cervical intraepithelial neoplasia grade 2 or worse...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31788

    authors: Fröberg M,Östensson E,Belkić K,Oštrbenk A,Poljak M,Mints M,Arbyn M,Andersson S

    更新日期:2019-01-15 00:00:00

  • Automated tobacco assessment and cessation support for cancer patients.

    abstract:BACKGROUND:Tobacco assessment and cessation support are not routinely included in cancer care. An automated tobacco assessment and cessation program was developed to increase the delivery of tobacco cessation support for cancer patients. METHODS:A structured tobacco assessment was incorporated into the electronic heal...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28440

    authors: Warren GW,Marshall JR,Cummings KM,Zevon MA,Reed R,Hysert P,Mahoney MC,Hyland AJ,Nwogu C,Demmy T,Dexter E,Kelly M,O'Connor RJ,Houstin T,Jenkins D,Germain P,Singh AK,Epstein J,Dobson Amato KA,Reid ME

    更新日期:2014-02-15 00:00:00

  • Radiotherapy or surgery for head and neck squamous cell cancer: establishing the baseline for hypopharyngeal carcinoma?

    abstract:BACKGROUND:The authors compared the survival outcomes of radiotherapy+/-salvage surgery to surgery+/-postoperative radiotherapy for patients with squamous cell cancer of the hypopharynx. There was no evidence beyond observational studies and no consensus on the which treatment is most effective for this patient group. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24635

    authors: Hall SF,Groome PA,Irish J,O'Sullivan B

    更新日期:2009-12-15 00:00:00

  • A new method for analyzing the cell kinetics of human brain tumors by double labeling with bromodeoxyuridine in situ and with iododeoxyuridine in vitro.

    abstract:BACKGROUND:Cell kinetics studies performed with immunohistochemical techniques to estimate the S-phase fraction have elucidated the proliferative potential of individual brain tumors. METHODS:The authors developed a new double-labeling method that enables other cell kinetics variables, including the duration of the S-...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930515)71:10<3109::aid-cncr282

    authors: Shibuya M,Ito S,Davis RL,Wilson CB,Hoshino T

    更新日期:1993-05-15 00:00:00

  • Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer.

    abstract::Tumor-bearing patients with breast cancer were assayed for their natural killer (NK) cell activity and for the function of activated cytotoxic T-cells, as assessed by lectin-dependent cellular cytotoxicity (LDCC). Tumor-bearing patients with breast cancer had a significant increase in NK activity and in LDCC, as compa...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890515)63:10<1985::aid-cncr282

    authors: Zielinski CC,Tichatschek E,Müller C,Kalinowski W,Sevelda P,Czerwenka K,Kubista E,Spona J

    更新日期:1989-05-15 00:00:00

  • The occurrence of soft tissue sarcomas in three siblings with Werner's syndrome.

    abstract::Werner's syndrome, a relatively rare and autosomal recessive disorder, is well known to be characterized by a high frequency of malignant neoplasm. The occurrence of familial neoplasm in patients with this condition, however, has been recorded only once before in the literature. Reported are the findings with regard t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19841201)54:11<2580::aid-cncr282

    authors: Usui M,Ishii S,Yamawaki S,Hirayama T

    更新日期:1984-12-01 00:00:00

  • Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature.

    abstract:BACKGROUND:Onycholysis has been reported in association with the use of several noncytotoxic drugs and with chemotherapy in 135 patients. Onycholysis may be precipitated by exposure to ultraviolet radiation. METHODS:The authors studied 91 patients who received paclitaxel and 187 patients who received doxorubicin. RES...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/(sici)1097-0142(20000515)88:10<2367::aid-c

    authors: Hussain S,Anderson DN,Salvatti ME,Adamson B,McManus M,Braverman AS

    更新日期:2000-05-15 00:00:00

  • DNA ploidy of ovarian granulosa cell tumors. Lack of correlation between DNA index or proliferative index and outcome in 40 patients.

    abstract:BACKGROUND:Most cases of granulosa cell tumor of the ovary are characterized by relatively good outcome; however, some tumors behave aggressively, and some tend to recur many years after the initial diagnosis. Because DNA ploidy has been shown to predict biologic behavior better than conventional prognostic variables i...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950501)75:9<2295::aid-cncr2820

    authors: Evans MP,Webb MJ,Gaffey TA,Katzmann JA,Suman VJ,Hu TC

    更新日期:1995-05-01 00:00:00

  • Advocacy. Necessary to achieve cancer control goals.

    abstract::As resources become increasingly scarce, oncology professionals and consumers of oncology services are increasingly engaging in advocacy efforts to achieve goals in cancer control. Effective advocacy includes both legislative and direct educational efforts. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19911201)68:11+<2540::aid-cncr28

    authors: Berkman B,Stevenson E,Cravedi KG,Davis A,Lawrence W Jr,Mor V,Ostrander V,Rubenstein LJ,Speers M,Wilson K

    更新日期:1991-12-01 00:00:00

  • Selecting initial therapy for prostate cancer. Radiation therapy perspective.

    abstract::External-beam irradiation of prostatic cancer was introduced at Stanford in 1956. The program has sought to determine the following: whether prostatic carcinoma can be cured by external beam radiation therapy, with what frequency this can be accomplished, which patients are best suited for irradiation, and what techni...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870801)60:3+<521::aid-cncr2820

    authors: Bagshaw MA,Ray GR,Cox RS

    更新日期:1987-08-01 00:00:00

  • Relation of comorbidities and patient navigation with the time to diagnostic resolution after abnormal cancer screening.

    abstract:BACKGROUND:Whether patient navigation improves outcomes for patients with comorbidities is unknown. The aims of this study were to determine the effect of comorbidities on the time to diagnostic resolution after an abnormal cancer screening test and to examine whether patient navigation improves the timeliness and like...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30316

    authors: Whitley EM,Raich PC,Dudley DJ,Freund KM,Paskett ED,Patierno SR,Simon M,Warren-Mears V,Snyder FR,Patient Navigation Research Program Investigators.

    更新日期:2017-01-01 00:00:00

  • Combined modality therapy in Stage III and Stage IIIE diffuse large cell lymphomas.

    abstract::Combined modality therapy consisting of CHOP-Bleo (cyclophosphamide, Adriamycin [doxorubicin], vincristine (Oncovin), prednisone, and bleomycin) and limited-field radiotherapy was given to 47 patients with Stage III and IIIE diffuse large cell lymphomas. Overall 5-year survival and disease-free survival figures are 64...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840401)53:7<1478::aid-cncr2820

    authors: Velasquez W,Fuller LM,Oh KK,Hagemeister FB,Sullivan JA,Manning JT,Shullenberger CC

    更新日期:1984-04-01 00:00:00

  • Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults.

    abstract::One-hundred and fifty-one adults with acute non-lymphocytic leukemia (ANLL) were entered into an Eastern Cooperative Oncology Group protocol (EST-1473) comparing twice daily cytosine arabinoside and thioguanine (AT) with weekly cyclophosphamide, cytosine arabinoside, and methotrexate (CAM) for remission induction. Of ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19800115)45:2<224::aid-cncr28204

    authors: Skeel RT,Costello W,Bennett JM,Oken MM,Tobin MS,Bertino JR,Marsh JC,Carbone PP

    更新日期:1980-01-15 00:00:00